Montefiore Medical Center, 111 East 210th Street
Welcome,         Profile    Billing    Logout  
 5 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lukin, Dana
VERDICT, NCT04259138: Determination of the Optimal Treatment Target in Ulcerative Colitis

Active, not recruiting
4
672
Europe, Canada, US, RoW
Treatment Algorithm A, vedolizumab, Treatment Algorithm B, Treatment Algorithm C
Alimentiv Inc., Takeda Development Center Americas, Inc.
Colitis, Ulcerative
03/26
03/26
NCT06095128: A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Recruiting
4
65
Canada, US
Vedolizumab, Entyvio, MLN0002, Tofacitinib, Xeljanz, CP-690, CP-550
Takeda
Ulcerative Colitis
07/27
07/27
NCT06274554: Testing the Role for Anti-fungal Therapy in Improving the Response to Medicine for Crohn's Disease

Not yet recruiting
3
120
US
Fluconazole, Diflucan, Placebo, IL-23 Therapy, Risankizumab, Ustekinumab
Weill Medical College of Cornell University, The Leona M. and Harry B. Helmsley Charitable Trust
Crohn's Disease, Inflammatory Bowel Diseases
12/28
12/29
MINDFUL, NCT03998488: Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

Completed
2
27
US
Fecal Microbiota Transplantation, FMP250, FMT, Psyllium Husk Powder
Weill Medical College of Cornell University, Crohn's and Colitis Foundation, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Ulcerative Colitis, Inflammatory Bowel Diseases
06/23
04/24
PL8177-205, NCT05466890: Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)

Recruiting
2
28
US
PL8177 Placebo, Placebo, PL8177, Active study medication
Palatin Technologies, Inc
Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare
04/24
08/24
NCT06109441: Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

Recruiting
2
30
Canada, US
ALTB-268
AltruBio Inc.
Ulcerative Colitis
04/25
03/26
NCT03952364: The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States

Recruiting
N/A
200
US
PredictSURE IBD™
PredictImmune Ltd, The Crohn's and Colitis Foundation
Crohn Disease, Ulcerative Colitis, IBD, Inflammatory Bowel Diseases
06/22
06/22
NCT04672161: Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients

Completed
N/A
200
US
Vaccine Education
Weill Medical College of Cornell University
Crohn Disease (CD), Ulcerative Colitis (UC), Indeterminate Colitis
06/22
06/23
QUOTIENT, NCT05230173: Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting
N/A
250
US
Pragmatic
University of California, San Diego, Baylor College of Medicine, Crohn's and Colitis Foundation, Western University, Patient-Centered Outcomes Research Institute
Ulcerative Colitis, Crohn Disease
03/28
06/28
HBOT-UC, NCT05987852: Hyperbaric Oxygen Therapy for Ulcerative Colitis

Recruiting
N/A
126
US
Hyperbaric Oxygen Therapy, Sham Hyperbaric Air
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Ulcerative Colitis
09/27
09/27
Abd, Mortadha
No trials found

Download Options